Lux Capital is the famous VC, which was founded in 2000. The company was established in North America in United States. The main department of described VC is located in the New York.
When the investment is from Lux Capital the average startup value is 500 millions - 1 billion dollars. The fund is constantly included in 13-24 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top activity for fund was in 2017. Opposing the other organizations, this Lux Capital works on 21 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Lux Capital, startups are often financed by General Catalyst, GV, Union Square Ventures. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Montage Ventures, Dolby Family Ventures. In the next rounds fund is usually obtained by Venrock, Kleiner Perkins, Bill Gates.
The current fund was established by Josh Wolfe, Peter Hebert, Rob Paull. Besides them, we counted 13 critical employees of this fund in our database.
The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Auris Health, Inc., Zoox, Desktop Metal. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Software, Health Care.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Hadrian | $92M | 21 Feb 2024 | San Francisco, California, United States | ||
ZEDEDA | $72M | 07 Feb 2024 | San Jose, California, United States | ||
Coris | $3M | 01 Feb 2024 | San Francisco, California, United States | ||
Sakana AI | $30M | 16 Jan 2024 | Tokyo, Kantō, Japan | ||
Inductive Bio | $4M | 13 Dec 2023 | - | ||
Armada | $55M | 11 Dec 2023 | - | ||
Instock | $3M | 07 Dec 2023 | Burlingame, California, United States | ||
Cromatic | $5M | 09 Nov 2023 | San Francisco, California, United States | ||
Factory | $5M | 02 Nov 2023 | - |
– Atavistik Bio, a pre-clinical biotechnology company pioneering the identification of metabolite-protein interactions that have the potential to lead to the discovery and development of first-in-class drug candidates powered by distinct allosteric control mechanisms, announced that the closing of a $60 million Series A financing round.
– The financing was led by The Column Group and joined by Lux Capital, and Nextech Invest.
– The new financing will support development of Atavistik’s drug discovery platform, and future identification of select drug candidates based on deep knowledge of disease relevant pathways that have evolved over millions of years by nature to be allosterically regulated by metabolites.
– Ramp announced that it closed a $300m series C funding tranche led by Founders Fund, with participation from Redpoint Ventures, Thrive Capital, D1 Capital Partners, Spark Capital, Coatue Management, Iconiq, Altimeter, Stripe, Lux Capital, A* Partners, and Definition Capital.
– Ramp provides virtual and physical cards that offer 1.5% cashback on purchases. Its management tools allows companies to control spend with multi-level rules, vendor spending limits, merchant blacklists, and approvals, as well as spending insights that combine expense reporting, accounting, and more.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Hadrian | $92M | 21 Feb 2024 | San Francisco, California, United States | ||
ZEDEDA | $72M | 07 Feb 2024 | San Jose, California, United States | ||
Coris | $3M | 01 Feb 2024 | San Francisco, California, United States | ||
Sakana AI | $30M | 16 Jan 2024 | Tokyo, Kantō, Japan | ||
Inductive Bio | $4M | 13 Dec 2023 | - | ||
Armada | $55M | 11 Dec 2023 | - | ||
Instock | $3M | 07 Dec 2023 | Burlingame, California, United States | ||
Cromatic | $5M | 09 Nov 2023 | San Francisco, California, United States | ||
Factory | $5M | 02 Nov 2023 | - |